476 related articles for article (PubMed ID: 17973271)
1. Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action.
Astudillo P; Ríos S; Pastenes L; Pino AM; Rodríguez JP
J Cell Biochem; 2008 Mar; 103(4):1054-65. PubMed ID: 17973271
[TBL] [Abstract][Full Text] [Related]
2. Differential activation of ERK1,2 MAP kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal women.
Rodríguez JP; Ríos S; Fernández M; Santibañez JF
J Cell Biochem; 2004 Jul; 92(4):745-54. PubMed ID: 15211572
[TBL] [Abstract][Full Text] [Related]
3. 20(S)-hydroxycholesterol inhibits PPARgamma expression and adipogenic differentiation of bone marrow stromal cells through a hedgehog-dependent mechanism.
Kim WK; Meliton V; Amantea CM; Hahn TJ; Parhami F
J Bone Miner Res; 2007 Nov; 22(11):1711-9. PubMed ID: 17638575
[TBL] [Abstract][Full Text] [Related]
4. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood.
Chang YJ; Shih DT; Tseng CP; Hsieh TB; Lee DC; Hwang SM
Stem Cells; 2006 Mar; 24(3):679-85. PubMed ID: 16179428
[TBL] [Abstract][Full Text] [Related]
5. Human osteoblasts derived from mesenchymal stem cells express adipogenic markers upon coculture with bone marrow adipocytes.
Clabaut A; Delplace S; Chauveau C; Hardouin P; Broux O
Differentiation; 2010 Jul; 80(1):40-5. PubMed ID: 20466479
[TBL] [Abstract][Full Text] [Related]
6. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Volloch V; Kaplan DL
Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures.
Justesen J; Stenderup K; Eriksen EF; Kassem M
Calcif Tissue Int; 2002 Jul; 71(1):36-44. PubMed ID: 12200657
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis.
Elabd C; Basillais A; Beaupied H; Breuil V; Wagner N; Scheideler M; Zaragosi LE; Massiéra F; Lemichez E; Trajanoski Z; Carle G; Euller-Ziegler L; Ailhaud G; Benhamou CL; Dani C; Amri EZ
Stem Cells; 2008 Sep; 26(9):2399-407. PubMed ID: 18583541
[TBL] [Abstract][Full Text] [Related]
9. Osteogenic potential and responsiveness to leptin of mesenchymal stem cells between postmenopausal women with osteoarthritis and osteoporosis.
Zhang ZM; Jiang LS; Jiang SD; Dai LY
J Orthop Res; 2009 Aug; 27(8):1067-73. PubMed ID: 19215023
[TBL] [Abstract][Full Text] [Related]
10. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
Chen ZX; Chang M; Peng YL; Zhao L; Zhan YR; Wang LJ; Wang R
Regul Pept; 2007 Jul; 142(1-2):16-23. PubMed ID: 17331598
[TBL] [Abstract][Full Text] [Related]
11. [Adipogenesis and osteoporosis].
Rodríguez JP; Astudillo P; Ríos S; Seitz G; Pino AM
Rev Med Chil; 2009 Jun; 137(6):827-36. PubMed ID: 19746287
[TBL] [Abstract][Full Text] [Related]
12. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages.
Liu TM; Martina M; Hutmacher DW; Hui JH; Lee EH; Lim B
Stem Cells; 2007 Mar; 25(3):750-60. PubMed ID: 17095706
[TBL] [Abstract][Full Text] [Related]
13. (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation.
Shin DW; Kim SN; Lee SM; Lee W; Song MJ; Park SM; Lee TR; Baik JH; Kim HK; Hong JH; Noh M
Biochem Pharmacol; 2009 Jan; 77(1):125-33. PubMed ID: 18951882
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis-associated alteration in the signalling status of BMP-2 in human MSCs under adipogenic conditions.
Donoso O; Pino AM; Seitz G; Osses N; Rodríguez JP
J Cell Biochem; 2015 Jul; 116(7):1267-77. PubMed ID: 25640452
[TBL] [Abstract][Full Text] [Related]
15. Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis.
Rodríguez JP; Astudillo P; Ríos S; Pino AM
Curr Stem Cell Res Ther; 2008 Sep; 3(3):208-18. PubMed ID: 18782003
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17A increases leptin production in human bone marrow mesenchymal stem cells.
Noh M
Biochem Pharmacol; 2012 Mar; 83(5):661-70. PubMed ID: 22197587
[TBL] [Abstract][Full Text] [Related]
17. PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells.
Yu WH; Li FG; Chen XY; Li JT; Wu YH; Huang LH; Wang Z; Li P; Wang T; Lahn BT; Xiang AP
Int J Biochem Cell Biol; 2012 Feb; 44(2):377-84. PubMed ID: 22120652
[TBL] [Abstract][Full Text] [Related]
18. EMF acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
Yang Y; Tao C; Zhao D; Li F; Zhao W; Wu H
Bioelectromagnetics; 2010 May; 31(4):277-85. PubMed ID: 20041434
[TBL] [Abstract][Full Text] [Related]
19. Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells.
Schilling T; Nöth U; Klein-Hitpass L; Jakob F; Schütze N
Mol Cell Endocrinol; 2007 Jun; 271(1-2):1-17. PubMed ID: 17475397
[TBL] [Abstract][Full Text] [Related]
20. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression.
Zhang L; Su P; Xu C; Chen C; Liang A; Du K; Peng Y; Huang D
J Pineal Res; 2010 Nov; 49(4):364-72. PubMed ID: 20738756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]